悦心健康(002162) - 2023 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2023 was ¥221,065,012.52, representing an increase of 18.52% compared to ¥186,519,515.45 in the same period last year[5] - The net profit attributable to shareholders was -¥7,672,898.23, an improvement of 49.83% from -¥15,294,690.85 year-on-year[5] - The net cash flow from operating activities improved by 55.51%, reaching -¥43,674,374.02 compared to -¥98,177,017.43 in Q1 2022[13] - The company reported a 288.99% increase in investment income, amounting to ¥2,208,237.86, primarily due to dividends received from an associate[11] - The gross profit from tile sales increased by approximately 22% year-on-year, contributing an additional ¥5,500,000 to gross profit[12] - Total operating revenue for Q1 2023 was CNY 221,065,012.52, an increase of 18.5% compared to CNY 186,519,515.45 in the same period last year[20] - Net loss for Q1 2023 was CNY 7,679,632.24, compared to a net loss of CNY 15,314,285.60 in Q1 2022, representing a 50.2% improvement[22] - Basic and diluted earnings per share for Q1 2023 were both CNY -0.0083, an improvement from CNY -0.0165 in Q1 2022[22] Cash Flow - The net cash flow from financing activities significantly increased by 290.91%, reaching ¥72,231,449.31 compared to -¥37,836,020.70 in the same period last year[13] - The net cash flow from operating activities increased year-on-year due to higher sales receipts[15] - The net cash flow from investing activities increased year-on-year due to government compensation received for land[15] - Cash inflow from operating activities totaled CNY 303,136,419.50, compared to CNY 258,874,466.32 in the same period last year, reflecting a growth of 17.1%[23] - The total cash and cash equivalents at the end of the period amounted to ¥165,799,949.86, an increase from ¥141,167,358.41 at the beginning of the period[24] - The company experienced a net increase in cash and cash equivalents of ¥24,632,591.45, contrasting with a decrease of -¥149,926,772.02 in the previous period[24] - The company received cash from borrowings totaling ¥100,000,000.00[24] - The company distributed dividends and interest payments totaling ¥8,485,965.13[24] Assets and Liabilities - Total assets decreased by 2.38% to ¥2,431,037,643.33 from ¥2,490,346,685.37 at the end of the previous year[5] - The total assets amounted to 2,431,037,643.33 yuan, a decrease from 2,490,346,685.37 yuan at the beginning of the year[18] - Current liabilities totaled 902,864,858.04 yuan, down from 953,990,135.67 yuan at the beginning of the year[18] - The company's long-term borrowings were 300,000,000 yuan, slightly down from 303,750,000 yuan at the beginning of the year[18] - The total liabilities were 1,407,361,703.10 yuan, a decrease from 1,473,317,979.11 yuan at the beginning of the year[18] - The company's capital reserve increased to 196,283,288.37 yuan from 195,436,092.77 yuan at the beginning of the year[18] - The company reported a total of 898,448,318.05 yuan in current assets, down from 942,685,963.79 yuan at the beginning of the year[16] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 71,020, with no preferred shareholders having restored voting rights[14] - CIMIC INDUSTRIAL INC. holds 38.41% of shares, amounting to 355,896,164 shares, with 100 million shares pledged[14] Research and Development - The company received government subsidies of ¥166,563.40 related to R&D investments during the reporting period[6] - Research and development expenses for Q1 2023 were CNY 1,768,801.66, a decrease of 19.9% from CNY 2,210,031.22 in the same period last year[20] Other Information - The company established a new non-wholly-owned subsidiary, resulting in a 124.75% increase in minority interests to ¥24,254,863.72[9] - The impact of exchange rate changes on cash and cash equivalents was a decrease of -¥11,112.98[24] - The company did not undergo an audit for the first quarter report[25] - The report was presented by the board of directors on April 26, 2023[26]